【持续性肾脏替代治疗crrt英文精品课件】treatment related factors_第1页
【持续性肾脏替代治疗crrt英文精品课件】treatment related factors_第2页
【持续性肾脏替代治疗crrt英文精品课件】treatment related factors_第3页
【持续性肾脏替代治疗crrt英文精品课件】treatment related factors_第4页
【持续性肾脏替代治疗crrt英文精品课件】treatment related factors_第5页
已阅读5页,还剩68页未读 继续免费阅读

下载本文档

版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领

文档简介

1 TreatmentRelatedFactors CatheterperformanceQBtendsberoughlycomparableforFEandR sidedSCandIJlinesMaximumachievableQBtendstobelowerby 100mL mininL sidedSCandIJlinesARtendstobehighestinshortFElines intermediateinlongFElines andlowestinSCandIJlinesDialyzerandfilterperformanceOliveretal SeminDial Vol14 pp432 435 2001Littleetal AJKD Vol36 pp1135 1139 2000Margettsetal JASN Vol10 pp211A 1999 2 Littleetal AJKD Vol36 pp1135 1139 2000 3 A IJcatheterwithnorecirculation B 20cmFEcatheterassumedtohaveARof0 at150mL min 8 5 at250mL minand17 at350mL min C 15cmFEcatheterassumedtohaveARof5 at150mL min 20 at250mL minand30 at350mL min iHDtreatmentsaremodelledunderthefollowingconditions duration240mins dialysateflow500mL min hemodialyzermasstransfercoefficient911mL min V40L nPCR0 8g kg day 4 TreatmentRelatedFactors Catheterperformance Dialyzer iHDandHybrid performanceHeparin freeiHDisassociatedwithsignificantfibrebundleclotting andalsowithreduceddeliverediHDdoseKdecreasesby10 20 duringinthehourbeforedialyzerclottingduringHybridTherapyLow fluxdialyzersareassociatedwithloweriHDdose KoA QD Sakiewiczetal JASN Vol10 pp196A 1999Evansonetal AJKD Vol32 pp731 738 1998Marshalletal UpToDate SustainedLow EfficiencyDialysis Paganinietal AmJKidneyDis Vol28 Suppl ppS81 S89 1996 5 MarshallandGolper UpToDate SustainedLow EfficiencyDialysis 6 TreatmentRelatedFactors Catheterperformance Filter CRRT performanceDowntimeduetofilterclottingisthemajorreasonforreducedCRRTdose 7 8 TreatmentRelatedFactors CatheterperformanceFilter CRRT performanceDowntimeduetofilterclottingisthemajorreasonforreducedCRRTdoseConcentrationpolarizationreducesfiltrationrateandthefiltrateconcentrationsofvariousmedium largesizedproteinsHighfiltrationfraction highUF lowQBorpostdilution isassociatedwithbothofabovePre dilutionversuspost dilution 9 TreatmentRelatedFactors 10 TreatmentRelatedFactors ForiHD longcathetersshouldbeusedforfemoralangioaccess andadjustdoseprescriptioninanticipationofincreasedARForiHD canadjustforsolutecompartmentalizationusingtheDaugirdas Garred orTattersallrateequationsForbothiHDandCRRT optimizeanticoagulationandadjustdoseprescriptionintheadventofdialyzerandfilterclotting 11 TreatmentRelatedFactors ForCRRT avoidhighfiltrationfractionbyhigherbloodflowratesandpre dilutiontominimizeconcentrationpolarizationandhemoconcentrationExceptusingRegionalCitrateAnticoagulationwithpost dilutionreplacementForCRRT adjustprescriptionforpredilutionwitheitheraFUN BUNratiooranempirical15 forlower doseprescriptions 2L hr and30 40 forhigher doseprescriptions 4L hr 12 Overview RevisitingofdoseandoutcomesPatientandtreatmentrelatedfactorsaffectingdoseprescriptionanddeliveryTherapy specificdose outcomedataApproachtoprescriptionandquantificationofacuteRRTdose 13 Dose OutcomeDataCRRT 14 15 TableI ClinicalDiagnosisofstudypatients 16 NotRandomized 17 18 19 20 21 22 23 24 Dose OutcomeData CRRT Doseisquantifiedaseffluent filtration rateindexedtobodysizeAdoseof35mL kg hrinpost dilutionmodeisreportedasgivingthebestresultsStartingacuteRRTearlierratherthanlaterissuggestedasgivingthebestresults 25 Dose OutcomeDataiHD 26 27 28 29 30 31 32 33 34 35 36 37 38 Dose OutcomeData iHD Doseisquantifiedasclearanceindexedtosolutepoolsize singlepoolKt V Adoseof 1 0isreportedasgivingthebestresultsDailyiHDisreportedasgivingbetterresultsthatalternatedayiHD 39 40 Phuetal 70patientswithsepsisrandomizedtoCVVHorCAPDAverageweight53kgMostcommondiagnosisfalciparummalariaCVVH25L daypre dilutionlactatebasedsubstitutionfluidrate Ku25L dayCAPD70L daydialysateexchanged Ku28L day 41 CAPDprovidedunsatisfactorycontrolofcidosis longerdurationofARF poorersurvival 42 Overview RevisitingofdoseandoutcomesPatientandtreatmentrelatedfactorsaffectingdoseprescriptionanddeliveryTherapy specificdose outcomedataApproachtoprescriptionandquantificationofacuteRRTdose 43 CRRTPrescription ForallCRRT aimfor 85 deliveryofprescribeddoseForallCRRT aimforeffluentrateof 35mL kg hr withappropriateadjustmentsfortheeffectofpre dilution andaccountingforpatientandtreatmentrelatedbarriers 44 CRRTPrescription ItisunlikelyCVVHcanachieveaneffluentrateof35mL kg hrwithouthighbloodflowrate pre dilutionExceptthepatientissmall pediatric ornotparticularlysickorUsingRegionalCitrateAnticoagulation post dilutionTheadequacyofaneffluentrateof35mL kg hrisunclearforCVVHD F sincethisdoseappliestodialysategeneratedbydiffusionratherthanfiltrategeneratedbyconvection 45 iHDPrescription ItisunlikelythatiHDcandeliveranadequatedoseoutsideofadailyornear dailyregimenunlessthepatientisunlessthepatientissmall pediatric ornotparticularlysickFordailyiHD aimforadeliveredsinglepoolKt Vofatleast 1 0 accountingforpatientandtreatmentrelatedbarriers prescribe1 3 46 iHDPrescription ThemostpracticalexpressionofiHDdoseissinglepoolKt V andismostaccuratelyachievedbyformalUKMThemostrealisticexpressioniHDdoseisequilibratedKt V andismostaccuratelyachievedbyadjustingsinglepoolKt VusingtheDaugirdas Garred orTattersallrateequations 47 PDPrescription ItisevenlesslikelythatPDcandeliveranadequatedoseoutsideofcontinuousflowPDunlessthepatientissmall pediatric ornotparticularlysick 48 DoseandTherapyChoice IfiHDisnotdeliveringadequatedosedespiteoptimizingallfactors tryHybridTherapyorCRRTIfCRRTisnotdeliveringadequatedosedespiteoptimizingallfactors tryHybridTherapyoriHDThereareincreasingdatasuggestingthatdelayingacuterenalreplacementtherapyincriticallyillpatientsisunwise 49 IsthereanexpressionofacuteRRTdosethatwillallowustoreconcilethesedifferentrecommendationsforiHDandCRRT 50 StandardKt V stdKt V Units week 1 51 52 53 stdKt V RequiresasolutesteadystateforcalculationExpressesacuteRRTdoseasanewlessintuitiveparameterBasedonpeak concentrationhypothesis whichcanreconcileKt VstandardsforCAPDandiHDdoseintheoutpatientsetting butisarbitraryanddifficulttodefineinthecriticallyill 54 CorrectedEquivalentRenalUreaClearance EKRc Units mL min 55 G TACorJ TAC 56 AcomparisonofBUNtime concentrationprofilesbetweentwointermittenthemodialysisregimensdeliveringacEKRof24ml min Thesolidlinereflectssoluteremovalover3treatmentsperweek thedottedsoluteremovalover7treatmentsperweek 57 EKRc 1stGeneration AnalogoustoGFR conceptuallysimplesinceitexpressesacuteRRTdoseasmL minIscorrectedforbodysize a70kgpersonwithaVof40LorBSAof1 73m2 I

温馨提示

  • 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
  • 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
  • 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
  • 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
  • 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
  • 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
  • 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。

评论

0/150

提交评论